Literature DB >> 16164577

Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000.

A Rautio1, V Lundberg, T Messner, S Nasic, B Stegmayr, M Eliasson.   

Abstract

BACKGROUND: The aim of this study was to compare time trends in incidence, case fatality and mortality due to myocardial infarction (MI) in patients with or without diabetes.
METHODS: This study was based on the Northern Sweden MONICA Project MI registry with a target population of about 200,000 inhabitants in the age group 35--64 years in the two northernmost counties of Sweden. During 1989--2000, 6254 patients who had had an MI according to MONICA criteria were included in this study: 4569 patients had a first MI and 1685 had a recurrent MI. Sixteen per cent of the men and 20% of the women had had diabetes mellitus diagnosed prior the MI.
RESULTS: Over the 12-year period, there was a declining trend in incidence and case fatality in first MI. Also, the event rates (first ever and recurrent MI) declined in men without diabetes. In women without diabetes favourable time trends were seen in first ever MI, recurrent MI and in case fatality. There were no favourable time trends for any of these outcomes in patients with diabetes.
CONCLUSION: In nondiabetic subjects below the age of 65, the incidence of, and case-fatality in, MI declined. This led to a decreased mortality over the 12-year period. These favourable trends over time were not observed in diabetic subjects.

Entities:  

Mesh:

Year:  2005        PMID: 16164577     DOI: 10.1111/j.1365-2796.2005.01552.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Mortality after first myocardial infarction in diabetic and non-diabetic people between 1985 and 2009. The MONICA/KORA registry.

Authors:  Andrea Icks; Heiner Claessen; Inge Kirchberger; Margit Heier; Annette Peters; Ines Trentinaglia; Guido Giani; Wolfgang von Scheidt; Christa Meisinger
Journal:  Eur J Epidemiol       Date:  2014-11-01       Impact factor: 8.082

2.  Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend.

Authors:  K M Winell; R Pääkkönen; A Pietilä; M K Niemi; A R Reunanen; V V Salomaa
Journal:  Diabetologia       Date:  2009-12-09       Impact factor: 10.122

3.  Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry.

Authors:  A Icks; T Dickhaus; A Hörmann; M Heier; G Giani; B Kuch; C Meisinger
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

Review 4.  Type 2 diabetes and cardiovascular disease in women.

Authors:  A Norhammar; K Schenck-Gustafsson
Journal:  Diabetologia       Date:  2012-09-04       Impact factor: 10.122

5.  Prevalence and incidence of diabetes in Stockholm County 1990-2010.

Authors:  Tomas Andersson; Anders Ahlbom; Cecilia Magnusson; Sofia Carlsson
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

6.  Improved survival in both men and women with diabetes between 1980 and 2004--a cohort study in Sweden.

Authors:  Mats Eliasson; Mats Talbäck; Måns Rosén
Journal:  Cardiovasc Diabetol       Date:  2008-10-20       Impact factor: 9.951

7.  Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study.

Authors:  Judith Charlton; Radoslav Latinovic; Martin C Gulliford
Journal:  Diabetes Care       Date:  2008-05-28       Impact factor: 19.112

8.  Gender differences in trends of acute myocardial infarction events: the Northern Sweden MONICA study 1985 - 2004.

Authors:  Dan Lundblad; Lars Holmgren; Jan-Håkan Jansson; Ulf Näslund; Mats Eliasson
Journal:  BMC Cardiovasc Disord       Date:  2008-07-25       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.